MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Natural history and disease progression biomarkers of multiple system atrophy: the ASPIRE-MSA study

    N. Del Campo, P. Péran, P. Payoux, V. Rousseau, A. Drif, H. Catalá, C. Thalamas, C. Tranchant, F. Duriff, A. Marques, JP. Azulay, C. Moreau, JC. Corvol, S. Thobois, AG. Corbille, S. Frismand, B. Patterson, A. Foubert-Samier, A. Pavy-Letraon, M. Fabbri, W. Meissner, O. Rascol (Toulouse, France)

    Objective: To evaluate multiple system atrophy (MSA) disease progression on a panel of candidate MSA biomarkers pre-selected for their putative involvement in the pathophysiology of…
  • 2023 International Congress

    Differences of social and clinical factors related with distribution of DBS in Mexican PD population

    MF. Medina Pérez, DR. Aguila Godinez, AA. Herrera Ruiz, EC. Santiago Cruz, LG. Lira Juárez, MAG. Medrano Delgado, MA. Ruiz Mafud, AJ. Hernández-Medrano, AY. Regalado Mustafá, DP. Romero-Terán, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, AG. Alcocer-Salas (Mexico, Mexico)

    Objective: To identify which social and clinical factors are related to disparities between the distribution of DBS in Mexican PD population Background: Deep Brain stimulation…
  • 2023 International Congress

    Clinical toolkits to improve conversations about Parkinson’s dementia

    I. Dobreva, J. Thomas, M. Roche, C. Dore, S. Rose, S. Baldwin-Jones, R. O'Connell, A. Marr, C. Hugill, R. Weil (London, United Kingdom)

    Objective: To co-produce, with people living with Parkinson’s and professionals, a pair of toolkits to improve conversations about Parkinson’s dementia in the clinic: one for…
  • 2023 International Congress

    Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease

    EC. Santiago, AJ. Hernández Medrano, MA. Ruiz Mafud, AA. Herrera Ruiz, DR. Aguilar Godinez, LG. Lira Juárez, MA. Medrano Delgado, AM. Regalado Mustafá, A. Domínguez García, G. Hernandez Armesto, DP. Romero Terán, K. Talavera Lagunas, MF. Medina-Pérez, JF. García Hernández, A. Abundes-Corona, GI. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga (MÉXICO, Mexico)

    Objective: To describe the relation between dysphagia and body mass index and the increase in anxiety and depression in patients with parkinson’s disease. Background: Parkinson’s…
  • 2023 International Congress

    Correlation between dose of dopamine replacement therapy and King’s Parkinson’s Disease Pain Scale in Mexican Patients with Parkinson’s Disease

    A. Regalado Mustafá, D. Aguila Godinez, A. Herrera Ruiz, E. Santiago-de-La-Cruz, L. Lira Juárez, M. Medrano Delgado, M. Ruiz Mafud, A. Hernández-Medrano, D. Romero-Terán, M. Medina-Pérez, G. Cerda Hernández, M. Rodríguez-Violante, A. Cervantes-Arriaga, G. Hernandez Armesto, A. Abundes-Corona, A. Domínguez García, J. García Hernández, A. Alcocer Salas, K. Talavera Lagunas (Mexico City, Mexico)

    Objective: Investigate the relationship between the dose of dopamine replacement therapy (DRT) and pain severity as measured by the King's Parkinson's Disease Pain Scale (KPPS)…
  • 2023 International Congress

    Impact of non-pharmacological strategies on progression in Parkinson’s Disease and Cognitive Impairment.

    MAG. Medrano-Delgado, DR. Aguila-Godinez, MF. Ruiz-Mafud, LG. Lira-Juárez, EC. Santiago Delacruz, A. Domínguez-García, AJ. Hernández-Medrano, AY. Regalado-Mustafá, MF. Medina-Pérez, G. Hernandez-Armesto, K. Talavera-Laguna, A. Herrera-Ruiz, J. García-Hernández, DP. Romero-Terán, A. Alcocer-Salas, G. Cerda-Hernández, A. Abundes-Corona, M. Rodríguez-Violante, A. Cervantes-Arriaga (Ciudad de Mexico, Mexico)

    Objective: to determine the Impact of non-pharmacological strategies on progression in Parkinson's Disease and Cognitive Impairment. Background: PD is the second most common neurodegenerative disorder,…
  • 2023 International Congress

    Sacral Mass Lesion Mimicking Atypical Foot Dystonia In Parkinsonian Patient

    B. Barton (CHICAGO, USA)

    Objective: Describe an unusual presentation of leg posturing and dystonic features in a patient with diagnosis of atypical parkinsonism, which was ultimately found to be…
  • 2023 International Congress

    Alterations of the Right Olfactory Orbitofrontal Cortex and olfactory impairment in Parkinson’s Disease

    L. Pesantez Pacheco, M. Saquib, D. Ehrlich, M. Hallett, S. Horovitz (Bethesda, USA)

    Objective: To explore the potential role of the right olfactory orbitofrontal cortex in olfactory dysfunction (OD) in Parkinson’s Disease (PD). Background: The orbitofrontal cortex (OFC)…
  • 2023 International Congress

    Quantitative investigation of the pathway between dopamine receptors and Ca2+ channels in layer II stellate cells towards Parkinson’s disease

    C. Mahapatra, A. Pradhan (MUMBAI, India)

    Objective: Recent experimental data suggest a putative coupling between dopamine D2 receptors (D2R) and T-type Ca2+ channels as another biophysical explanation for the firing pattern…
  • 2023 International Congress

    Clinical features and phenoconversion risk in women with isolated REM sleep behavior disorder

    C. Alexandres, S. Mccarter, G. Tabatabai, L. Leclair-Visonneau, J. Feemster, T. Gossard, P. Timm, D. Sandness, J. Jagielski, E. Strainis, D. Carvalho, M. Junna, M. Lipford, J. Moore, M. Tippmann-Peikert, M. Silber, B. Boeve, E. ST. Louis (Rochester, USA)

    Objective: To determine features predictive of differential phenoconversion rates in isolated REM sleep Behavior Disorder (iRBD) to a defined neurodegenerative disease (NDD). Background: iRBD is…
  • « Previous Page
  • 1
  • …
  • 501
  • 502
  • 503
  • 504
  • 505
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley